150 related articles for article (PubMed ID: 8199535)
1. Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics.
Charles P; Mosekilde L; Risteli L; Risteli J; Eriksen EF
Bone Miner; 1994 Feb; 24(2):81-94. PubMed ID: 8199535
[TBL] [Abstract][Full Text] [Related]
2. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry.
Eriksen EF; Charles P; Melsen F; Mosekilde L; Risteli L; Risteli J
J Bone Miner Res; 1993 Feb; 8(2):127-32. PubMed ID: 8442431
[TBL] [Abstract][Full Text] [Related]
3. Assessment of bone formation by biochemical markers in metabolic bone disease: separation between osteoblastic activity at the cell and tissue level.
Charles P; Hasling C; Risteli L; Risteli J; Mosekilde L; Eriksen EF
Calcif Tissue Int; 1992 Dec; 51(6):406-11. PubMed ID: 1451006
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of biochemical markers in patients with metabolic bone disorders.
Hoshino H; Kushida K; Takahashi M; Kawana K; Denda M; Yamazaki K; Inoue T
Endocr Res; 1998 Feb; 24(1):55-64. PubMed ID: 9553754
[TBL] [Abstract][Full Text] [Related]
5. Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma.
Elomaa I; Virkkunen P; Risteli L; Risteli J
Br J Cancer; 1992 Aug; 66(2):337-41. PubMed ID: 1503907
[TBL] [Abstract][Full Text] [Related]
6. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
Katagiri M; Fukunaga M; Ohtawa T; Harada T
World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
[TBL] [Abstract][Full Text] [Related]
7. Type I collagen and procollagen fragments in patients with metabolic bone diseases.
Lin JS; Kao JT; Tsai KS
J Formos Med Assoc; 1996 Jul; 95(7):523-9. PubMed ID: 8840753
[TBL] [Abstract][Full Text] [Related]
8. [Studies of type I collagen related substances as bone metastatic markers of prostate carcinoma with special regard to serum carboxyterminal propeptide of type. I. Procollagen (PICP), cross-linked carboxyterminal telopeptide of type I collagen (ICTP) and Urinary deoxypyridinoline levels].
Imai T; Honda M; Maeda S; Hosoya Y; Arai T; Sumi S; Umeda H; Yano M; Koga F; Arai K; Yoshida K
Nihon Hinyokika Gakkai Zasshi; 1998 Apr; 89(4):484-91. PubMed ID: 9597867
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer.
Akimoto S; Akakura K; Shimazaki J
Jpn J Clin Oncol; 1996 Jun; 26(3):157-63. PubMed ID: 8656556
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer.
Tähtelä R; Thölix E
Anticancer Res; 1996; 16(4B):2289-93. PubMed ID: 8694558
[TBL] [Abstract][Full Text] [Related]
11. [Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) and carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia].
Tanaka K; Shiraishi K; Sakamoto A; Jojima H; Masuchi K; Okubo Y; Tanaka M; Fuzimatsu Y; Fukahori S; Osabe S; Imamura Y; Honda J; Oizumi K
Rinsho Ketsueki; 1998 Apr; 39(4):273-80. PubMed ID: 9597894
[TBL] [Abstract][Full Text] [Related]
12. Serum markers of type I collagen synthesis and degradation in amyotrophic lateral sclerosis.
Ono S; Imai T; Shimizu N; Nakayama M; Yamano T; Tsumura M
Eur Neurol; 2000; 44(1):49-56. PubMed ID: 10894996
[TBL] [Abstract][Full Text] [Related]
13. [Clinical usefulness of cross-linked N-telopeptide of type I collagen (NTx) as a bone metastatic marker in patients with prostate cancer--comparison with serum PICP, PINP and ICTP].
Kobayashi Y; Ochi M; Tokue A
Hinyokika Kiyo; 2000 Dec; 46(12):869-72. PubMed ID: 11211802
[TBL] [Abstract][Full Text] [Related]
14. [Serum concentration of pyridinoline cross-linked carboxy-terminal telopeptide of type-I collagen (ICTP) and carboxyterminal propeptide of human type I procollagen (PICP) in the diagnosis of bone metastases].
Koizumi M; Yamada Y; Takiguchi T; Suzuki C; Akashi T; Nomura E; Yamashita T; Ogata E
Kaku Igaku; 1996 Jan; 33(1):77-84. PubMed ID: 8819718
[TBL] [Abstract][Full Text] [Related]
15. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia.
Crofton PM; Ahmed SF; Wade JC; Stephen R; Elmlinger MW; Ranke MB; Kelnar CJ; Wallace WH
J Clin Endocrinol Metab; 1998 Sep; 83(9):3121-9. PubMed ID: 9745414
[TBL] [Abstract][Full Text] [Related]
16. Bone histomorphometry in celiac disease.
Arnala I; Kemppainen T; Kröger H; Janatuinen E; Alhava EM
Ann Chir Gynaecol; 2001; 90(2):100-4. PubMed ID: 11459257
[TBL] [Abstract][Full Text] [Related]
17. Normal serum indices of bone collagen biosynthesis and degradation in small for gestational age infants.
Namgung R; Tsang RC; Sierra RI; Ho ML
J Pediatr Gastroenterol Nutr; 1996 Oct; 23(3):224-8. PubMed ID: 8890070
[TBL] [Abstract][Full Text] [Related]
18. Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer.
Kylmälä T; Tammela TL; Risteli L; Risteli J; Kontturi M; Elomaa I
Br J Cancer; 1995 May; 71(5):1061-4. PubMed ID: 7734300
[TBL] [Abstract][Full Text] [Related]
19. Effects of infusion of parathyroid hormone and primary hyperparathyroidism on formation and breakdown of type I collagen.
Brahm H; Ljunggren O; Larsson K; Lindh E; Ljunghall S
Calcif Tissue Int; 1994 Dec; 55(6):412-6. PubMed ID: 7895178
[TBL] [Abstract][Full Text] [Related]
20. Concentrations of serum markers of type I collagen synthesis and degradation and serum osteocalcin in maternal and umbilical circulation.
Yasumizu T; Kato J
Endocr J; 1996 Apr; 43(2):191-5. PubMed ID: 8793335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]